Indian (NIFTY) Drug Retail Industry Analysis
UpdatedApr 27, 2024
DataAggregated Company Financials
Companies1
- 7D-2.8%
- 3M-6.6%
- 1Y-8.7%
- YTDn/a
In the last week, Drug Retail has been flat. As for the longer term, the industry has declined 7.0% in the last year. As for the next few years, earnings are expected to grow by 47% per annum.
Industry Valuation and Performance
Has the Indian Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 27 Apr 2024 | ₹80.7b | ₹53.9b | ₹586.6m | 137.6x | 137.6x | 1.5x |
| Mon, 25 Mar 2024 | ₹82.1b | ₹53.9b | ₹586.6m | 140x | 140x | 1.5x |
| Wed, 21 Feb 2024 | ₹85.1b | ₹53.9b | ₹586.6m | 145.1x | 145.1x | 1.6x |
| Fri, 19 Jan 2024 | ₹88.2b | ₹51.4b | ₹583.5m | 151.2x | 151.2x | 1.7x |
| Sun, 17 Dec 2023 | ₹89.8b | ₹51.4b | ₹583.5m | 153.9x | 153.9x | 1.7x |
| Tue, 14 Nov 2023 | ₹97.1b | ₹51.4b | ₹583.5m | 166.4x | 166.4x | 1.9x |
| Thu, 12 Oct 2023 | ₹92.6b | ₹48.5b | ₹503.5m | 183.8x | 183.8x | 1.9x |
| Sat, 09 Sep 2023 | ₹96.6b | ₹48.5b | ₹503.5m | 191.9x | 191.9x | 2x |
| Mon, 07 Aug 2023 | ₹111.9b | ₹45.6b | ₹497.6m | 225x | 225x | 2.5x |
| Wed, 05 Jul 2023 | ₹98.9b | ₹45.6b | ₹497.6m | 198.8x | 198.8x | 2.2x |
| Fri, 02 Jun 2023 | ₹95.9b | ₹45.6b | ₹497.6m | 192.7x | 192.7x | 2.1x |
| Sun, 30 Apr 2023 | ₹88.2b | ₹42.7b | ₹349.1m | 252.8x | 252.8x | 2.1x |
| Tue, 28 Mar 2023 | ₹79.0b | ₹42.7b | ₹349.1m | 226.2x | 226.2x | 1.8x |
| Thu, 23 Feb 2023 | ₹72.9b | ₹42.7b | ₹349.1m | 208.9x | 208.9x | 1.7x |
| Sat, 21 Jan 2023 | ₹74.6b | ₹40.1b | ₹386.7m | 192.9x | 192.9x | 1.9x |
| Mon, 19 Dec 2022 | ₹77.5b | ₹40.1b | ₹386.7m | 200.4x | 200.4x | 1.9x |
| Wed, 16 Nov 2022 | ₹74.1b | ₹40.1b | ₹386.7m | 191.8x | 191.8x | 1.8x |
| Fri, 14 Oct 2022 | ₹71.7b | ₹38.2b | ₹524.1m | 136.7x | 136.7x | 1.9x |
| Sun, 11 Sep 2022 | ₹87.8b | ₹38.2b | ₹524.1m | 167.5x | 167.5x | 2.3x |
| Tue, 09 Aug 2022 | ₹88.1b | ₹37.8b | ₹958.0m | 92x | 92x | 2.3x |
| Thu, 07 Jul 2022 | ₹90.8b | ₹37.8b | ₹958.0m | 94.8x | 94.8x | 2.4x |
| Sat, 04 Jun 2022 | ₹104.4b | ₹37.8b | ₹958.0m | 109x | 109x | 2.8x |
| Mon, 02 May 2022 | ₹118.7b | ₹36.2b | ₹1.0b | 115.9x | 115.9x | 3.3x |
| Wed, 30 Mar 2022 | ₹120.2b | ₹36.2b | ₹1.0b | 117.3x | 117.3x | 3.3x |
| Fri, 25 Feb 2022 | ₹115.4b | ₹36.2b | ₹1.0b | 112.7x | 112.7x | 3.2x |
| Sun, 23 Jan 2022 | ₹146.2b | ₹34.9b | ₹1.1b | 135.2x | 135.2x | 4.2x |
Price to Earnings Ratio
114.4x
Current Industry PE
- There is only one company in the Indian Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have declined 18% per year over the last three years.
- Meanwhile revenues for these companies have grown 16% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Indian Drug Retail compare with similar industries?
| IN Market | 2.61% | |
| Consumer Staples | 2.22% | |
| Food and Staples Retail | -2.97% | |
| Drug Retail | -2.75% | |
| Food Distributors | 1.64% | |
| Food Retail | -3.03% | |
| Big Box Super Stores | -4.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||